鶹ý

Tainted 'Male Enhancement' Pills; Green Card Freeze Hits Nursing; Monkeypox Rebounds

— Health news and commentary from around the Web gathered by 鶹ý staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require subscriptions.

The FDA issued multiple new that contain "potentially harmful hidden ingredients," some of which are found in prescription drugs.

Private equity-backed Envision Healthcare , but a group of emergency room doctors the controversial staffing firm anyway. (Reuters, KFF Health News)

Despite regulatory approval, for attention-deficit/hyperactivity disorder, insomnia, and opioid use disorder cannot be reimbursed by CMS. (Politico)

Gastroenterologists are flipping out over UnitedHealthcare's . (STAT)

Adults who reported had a greater risk of developing hypertension, a recent study found. (Washington Post)

A freeze on green cards could . (Politico)

Semaglutide (Wegovy) and other new weight-loss drugs are , according to the World Health Organization's (WHO) nutrition chief. (Reuters)

And a WHO report found that are losing momentum.

Why in Ohio since last summer. (Akron Beacon Journal)

Plus, in one rural New Mexico community without obstetric care, a vital could soon end. (NPR)

North Carolina Gov. Roy Cooper (D) vetoed a bill that ; republican lawmakers will likely attempt an override. (AP)

And Kansas Gov. Laura Kelly (D) vetoed a and prohibited officials from banning public gatherings due to infectious disease outbreaks. (The Hill)

U.S. cases of monkeypox, or mpox, . (Washington Post)

Despite a recall over possible bacterial contamination, lots of a certain Gerber infant formula were distributed to some retailers anyhow, .

Meanwhile, the FDA announced marketing denials to 10 companies for approximately. (Reuters)

A line drive that struck Colorado Rockies' pitcher Ryan Feltner in the head . (AP)

The Group of Seven, the world's richest nations, is expected to to developing countries. (Reuters)

  • author['full_name']

    Shannon Firth has been reporting on health policy as 鶹ý's Washington correspondent since 2014. She is also a member of the site's Enterprise & Investigative Reporting team.